Comparison of sublingual tablets with nitroglycerin complexed with β-cyclodextrin or titrated with crosspovidone - Technological approach

Acta Poloniae Pharmaceutica - Drug Research

Volumn 65, Issue 5, 2008, Pages 585-589

  Centkowska, Katarzyna ^a   Sznitowska, Małgorzata ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

cyclodextrin; Crosspovidone, sublingual tablets; Nitroglycerin; Stability, disintegration

Indexed keywords

BETA CYCLODEXTRIN; CROSPOVIDONE; DISINTEGRATING AGENT; GLYCERYL TRINITRATE; LACTOSE; MAGNESIUM STEARATE; POVIDONE; STARCH; STARLAC; TABLETOSE 80; UNCLASSIFIED DRUG;

ARTICLE; DRUG DOSAGE FORM COMPARISON; DRUG STABILITY; DRUG STORAGE; SUBLINGUAL DRUG ADMINISTRATION; TABLET DISINTEGRATION TIME; TABLET FORMULATION;

ADMINISTRATION, SUBLINGUAL; BETA-CYCLODEXTRINS; DRUG STABILITY; HUMANS; NITROGLYCERIN; TABLETS; TECHNOLOGY, PHARMACEUTICAL;

EID: 56849124568     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Stadler-Szöke A., Szejtli J.: Acta Pharm. Hung. 49, 30 (1979).
2. Frömming K.H., Szejtli J.: Cyclodextrins in Pharmacy. in: Topics in Inclusion Science, Vol. 5. Kluwer Academic Publishers, London 1994.
3. Kata M., Wayer M., Szabó-Révész P., Kedvessy G.Y., Stadler- Szöke A., Szejtli J.: Acta Pharm. Hung. 56, 157 (1979).
4. Pitha J., Harman M., Michel M.E.: J. Pharm. Sci. 75, 165 (1986).
5. Fridriksdottir H., Loftsson T., Gudmundsson J.A., Bjarnason G.J., Kjeld M., Thornsteinsson T.: Pharmazie 51, 39 (1996).
6. Jug M., Becirévic-Lacán M.: Eur. J. Pharm. Sci. 21, 251 (2004).
7. Loftsson T., Brewster M.E., Masson M.: Am. J. Drug Deliv. 2, 261 (2004).
8. Szejtli J., Szente L.: Eur. J. Pharm. Biopharm. 61, 115 (2005).
9. Loftsson T., Duchêne D.: Int. J. Pharm. 329, 1 (2006).
10. Krzek J., Moniczewska M., Zabierowska-Slusarczyk G.: J. Pharm. Biomed. Anal. 33, 403 (2003).